•  
  •  
 

Abstract

Introduction. Endothelial progenitor cell (EPC) is considered possible to reduce asymmetric dimethylarginine (ADMA) levels, which is a marker of improved endothelial function. However, clinically, there is still a debate about the role of EPC. This study was conducted to determine the correlation of elevated levels of erythropoietin (Epo) and the number of EPC CD34 + and CD133 + with improvement of endothelial function in renal failure patients 3 months after kidney transplantation. Methods. A cross-sectional study was conducted in prior and 3 months after kidney transplantation of renal failure patients who underwent a kidney transplant in Cipto Mangunkusumo hospital. The study included 21 subjects who enrolled from July 2013 to February 2014. Blood samples prior and 3 months after kidney transplantation were collected to evaluate the level of Epo, numbers of EPC CD34+ and CD133+ and level of assymetric dimethylarginine (ADMA). Statistical analysis was performed using Pearson or Spearman correlation test. Results. Results of this study showed that prior to kidney transplantation, level of Epo was increased but not statistically significant (p>0.05). The EPC numbers of CD34+ and CD133+ were significantly increased (p0.05). There was no association between the elevated level of Epo and the numbers of EPC CD34+ and CD133+ with the improvement of endothelial function three months after kidney transplantation. Conclusions. In three months after kidney transplantation, there is an elevated level of Epo, the numbers of EPC CD34+ and CD133+ and decrease level of ADMA. However, there was no association between the elevated level of Epo and the numbers of EPC CD34+ and CD133+ with the improvement of endothelial function in patients 3 months after kidney transplantation.

References

1. Susalit E. Persiapan perluasan fasilitas pengembangan pusat-pusat transplantasi di Indonesia. Jakarta: Departemen Kesehatan RI; 2013. 2. Marbun MBH. Perkembangan Transplantasi di Indonesia. Dalam: Siregar P, Dharmeizar, Nainggolan G, et al, editor. The 11th Jakarta Nephrology and Hypertension Course & Symposium on Hypertension. Jakarta: Pusat Penerbit PERNEFRI; 2011. hal.99-101 3. de Groot K, Bahlmann FH, Bahlmann E, Menne J, Haller H, Fliser D. Kidney graft function determines endothelial progenitor cell number in renal transplant recipients. Transplantation. 2005;79(8):941-5. 4. Soler MJ, Estrada OFM, Mari JMP, Marco-Feliu D, Oliveras A, Vila J, et al. Circulating endothelial progenitor cells after kidney transplantation. Am J Transplant. 2005;5(9):2154-9. 5. Fliser D. Perspectives in renal disease progression: the endothelium as a treatment target in chronic kidney diseases. J Nephrol. 2010;23(4):369-76. 6. Galle J, Quaschning T, Seibold S, Wanner C. Endothelial dysfunction and inflammation: what is the link? Kidney Int Suppl. 2003;63(24):S45-9. 7. Marco GS, Rustemeyer P, Brand M, Koch R, Kentrup D, Grabner A, et al. Circulating endothelial progenitor cells in kidney transplant patients. Pos one. 2011;6(9):e24046. 8. Hristov M, Erl W, Weber PC. Endothelial progenitor cells mobilization, differentiation and homing. Arterioscler thromb vasc biol. 2003;23(7):1185-9. 9. Chen YT, Cheng BC, Ko SF, Chen CH, Tsai TH, Leu S, et al. Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with CKD. Clin and Exp Nephrol. 2013;17(1):83-91. 10. Werner N, Nickening G. Influence of cardiovascular risk factors on EPC. Limitation for therapy? Arterioscler Thromb Vasc Biol. 2006;26(2):257-66. 11. Zoccali C, Kielstein JT. Asymmetric dimethylarginine: a new player in pathogenesis of renal disease? Curr Opin Nephrol Hypertens. 2006;15(3):314–20. 12. Kielstein J, Zoccali C. Asymmetric dimethylarginine: A cardiovascular risk factor and a uremic toxin coming of age? Am J of Kidney Diseases. 2005;46(2):186-202. 13. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15(8):1983–92. 14. Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined? J Cell Mol Med. 2009;13(1):87-102. 15. Werner N, Kosiol S, Schiegl, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353(10):999-1007. 16. Harun H, Susalit E, Marbun MB. Hubungan peningkatan kadar eritropoietin dengan perbaikan fungsi jantung pada pasien gagal ginjal yang menjalani transplantasi [Tesis]. [Jakarta]: Fakultas Kedokteran Universitas Indonesia; 2013 17. Townamchai N, Praditpornsilpa K, Ong E. Endothelial progenitor cells in Asian kidney transplant patients. Transp Proc. 2010;42(5):1690-4. 18. Susalit E. Diagnosis Dini Penyakit Ginjal Kronik. Dalam: Siregar P, Dharmeizar, Nainggolan G, et al. Penatalaksanaan Penyakit Ginjal Kronik. Edisi 1. Jakarta: Pusat Penerbit PERNEFRI; 2009. hal.9-13. 19. Bahlmann FH, Speer T, Fliser D. Endothelial progenitor cells in CKD. Nephrol Dial Transpl. 2010;25(2):341-6. 20. Gill JS, LAn J, Dong J, Rose C, Hendren E, Johnston O, et al. The survival benevit of kidney transplantation in obese patients. Am J of Transp. 2013;13(8):2019-83. 21. Herbrig K, Gebler K, Oelschlaegel U, Pistrosch F, Foerster S, Wagner A, et al. Kidney transplantation substantially improves endothelial progenitor cell dysfunction in patients with end stage renal disease. Am J Transplant. 2006;6(12):2922-8. 22. Hornum M, Clausen P, Idorn T, Hansen JM, Mathiesen ER, FeldtRasmussen B. Kidney transplantation improves arterial function measured by pulse wave analysis and endothelium-independent dilatation in uraemic patients despite deterioration of glucose metabolism. Nephrol Dial Transpl. 2011;26(7):2370-7. 23. Izzo JL, Taylor AA. The sympathetic nervous system and baroreflexes in hypertension and hypotension. Curr Hypertens Rep. 1999;1(3):254-63. 24. Abedini S, Meinitzer A, Holme I, März W, Weihrauch G, Fellstrøm B, et al. Asymetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients. Kidney Int. 2010;77(1):44-50. 25. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol. 2000;20(9):2032-7. 26. Molnar MZ, Tabag AG, Alam A, Czira ME, Rudas A, Ujszaszi A, et al. Serum Erythropoietin Level and Mortality in Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2011;6(12):2879-86. 27. Choukroun G, Kamar N, Dussol B, Etienne I, Cassuto-Viguier E, Toupance O, et al. Correction of post kidney transplant anemia reduce progression of allograft nephropathy. J Am Soc Nephrol. 2012;23(2):360-8. 28. Surdacki A, Marewicz E, Surdacka W, Rakowski T, Szastak G, Pryjma J, et al. Synergistic effects of ADMA accumulation and EPC deficiensy on renal function decline during a 2 year follow up in stable angina. Nephrol Dial Transplant. 2010;25(8):2576-83. 29. Scalera F, Kielstein T, Lobenhoffer JM, Postel SC, Täger M, BodeBöger SM. Erythropoietin increases ADMA in endothelial cells: role of dimethylarginine dimethylaminohydrolase. J Am Soc Nephrol. 2005;16(4):892-8. 30. Desai A, Zhao Y, Warren JS. Human recombinant Epo augments serum ADMA concentration but does not compromise NO generation in mice. Nephrol Dial Transplant. 2008;23(5):1513-20. 31. Steiner S, Winkelmayer WC, Kleinert J, Grisar J, Seidinger D, Kopp CW, et al. Endothelial progenitor cells in kidney transplant recipients. Transplantation. 2006;81(4):599-606. 32. Oflas H, Turkmen A, Turgut F, Pamukcu B, Umman S, Ucar A, et al. Changes in endothelial function before and after renal transplantation. Transplant Int. 2006;19(4):333-7.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.